154 reports of this reaction
1.5% of all AMANTADINE HYDROCHLORIDE reports
#19 most reported adverse reaction
INSOMNIA is the #19 most commonly reported adverse reaction for AMANTADINE HYDROCHLORIDE, manufactured by Bionpharma Inc.. There are 154 FDA adverse event reports linking AMANTADINE HYDROCHLORIDE to INSOMNIA. This represents approximately 1.5% of all 10,217 adverse event reports for this drug.
Patients taking AMANTADINE HYDROCHLORIDE who experience insomnia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INSOMNIA is a less commonly reported adverse event for AMANTADINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to insomnia, the following adverse reactions have been reported for AMANTADINE HYDROCHLORIDE:
The following drugs have also been linked to insomnia in FDA adverse event reports:
INSOMNIA has been reported as an adverse event in 154 FDA reports for AMANTADINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
INSOMNIA accounts for approximately 1.5% of all adverse event reports for AMANTADINE HYDROCHLORIDE, making it a notable side effect.
If you experience insomnia while taking AMANTADINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.